Riabni 55513-0224
Generic: Rituximab-Arrx
Product NDC
55513-0224- Manufacturer
- Amgen, Inc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 6, 2021
- Listing Expires
- December 31, 2026
- Application
- BLA761140
Need to source Riabni? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rituximab | 100 mg/10mL |
Drug Class
CD20-directed Cytolytic Antibody [EPC]CD20-directed Antibody Interactions [MoA]CD20-directed Cytolytic Antibody [EPC]
Packaging Options(2)
1 VIAL, SINGLE-DOSE in 1 CARTON (55513-224-01) / 10 mL in 1 VIAL, SINGLE-DOSE
1 VIAL, SINGLE-DOSE in 1 CARTON (55513-224-21) / 10 mL in 1 VIAL, SINGLE-DOSE